UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000031823
Receipt No. R000036346
Scientific Title A phase II trial evaluating the effect of olanzapine 5mg for breakthrough nausea and vomiting in patients receiving carboplatin based chemotherapy
Date of disclosure of the study information 2018/03/21
Last modified on 2019/03/29 23:43:12

No. Disposal Last modified on Item of update
1 Insert 2018/03/21 01:16:16
2 Update 2018/04/11 09:37:33 Recruitment status
Anticipated trial start date
3 Update 2018/09/22 22:10:19 Email1
4 Update 2018/09/22 22:11:12 Email1
5 Update 2019/03/22 23:34:31 Date of IRB
Last follow-up date
Date analysis concluded
6 Update 2019/03/22 23:37:30 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/03/29 23:42:10 Recruitment status
8 Update 2019/03/29 23:43:12 Number of participants that the trial has enrolled


Contact us.